Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Optimal Management of Dolutegravir Resistance: a Multi-country Cohort Study

NCT06762054 is registered in ClinicalTrials.gov with University of Nairobi as lead sponsor.

NCT NCT06762054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06762054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Optimal Management of Dolutegravir Resistance: a Multi-country Cohort Study
Lead sponsor
University of Nairobi
Phase
Observational
Overall status
Recruiting
Start date
March 3, 2025
Completion date
October 31, 2026
Enrollment
6,600 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection